术中肿瘤动脉直接插管技术,为部分中、晚期癌症病人的治疗提供了新的途径.但由于部分导管在体外留置,给病人带一了诸多不便。七十年代初,Blackshear首先设计并研制了皮下植入式输注泵,继而用于临床。随后国内也开展了对药泵的研究,我院于1990年9月～1992年9月使用西安生产的“KL—Ⅱ型皮下植入式抗癌药泵”治疗中、晚期部症病人30例,初步观察较满意,报告如下。临床资料男26例,女4例;平均年龄47.2岁(32～68岁)。其中原发性肝瘤27例,胰体部癌、胃癌及转移性肝癌各1例,诊断均经病理证实。导 The intraoperative direct arterial intubation technique provides a new approach for the treatment of some cancer patients in middle and late stages. However, due to the indwelling of some catheters in vitro, it has brought a lot of inconvenience to patients. In the early 1970s, Blackshear first designed and developed a subcutaneous implantable infusion pump, which was then used clinically. Subsequently, domestic research on drug pumps was also conducted. In September 1990-September 1992, we used the “KL-II Subcutaneous Implantable Anticancer Drug Pump” produced by Xi’an to treat 30 patients with middle and late stage disease symptoms. The preliminary observation was more satisfactory. The report is as follows. Clinical data were 26 males and 4 females; the average age was 47.2 years (32-68 years). Among them, 27 cases of primary hepatoma, 1 case of pancreatic cancer, gastric cancer and metastatic liver cancer were diagnosed by pathology. guide